bpc-157 regulatory status fda warning A U.S. Food and Drug Administration advisory committee has voted to recommend adding BPC-157, KPV and TB-500 to the FDA's list of bulk drug substances that can potentially be used by compounding BPC-157 + TB-500 · Hospira Bacteriostatic Water 30ml Potency:1 mg Cherry

bpc-157 regulatory status fda warning A U.S. Food and Drug Administration advisory committee has voted to recommend adding BPC-157, KPV and TB-500 to the FDA's list of bulk drug substances that can potentially be used by compounding BPC-157 + TB-500 · Hospira Bacteriostatic Water 30ml Potency:1 mg Cherry

BPC-157 + TB-500 · NOVALFAD

Refrigeration is mandatory for shelf life beyond a few days

Hospira Bacteriostatic Water 30ml

Potency:1 mg Cherry

Contraindications Based on mechanisms and theoretical considerations, BPC-157 may not be appropriate for: Individuals with active cancer Pregnant or breastfeeding women Those with uncontrolled cardiovascular conditions People taking anticoagulant medications (effects on bleeding unknown) Individuals with autoimmune conditions (immune modulation effects unclear) Quality and Purity Concerns Perhaps the most significant safety concern involves product quality